Hamilton Point Investment Advisors’s Anavex Life Sciences AVXL Stock Holding History

Hamilton Point Investment Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.3K	Hold	20,300	–	–	0.01%	155
2025 Q4	$72.3K	Hold	20,300	–	–	0.01%	158
2025 Q3	$181K	Hold	20,300	–	–	0.03%	131
2025 Q2	$187K	Hold	20,300	–	–	0.03%	129
2025 Q1	$174K	Hold	20,300	–	–	0.03%	123
2024 Q4	$218K	Hold	20,300	–	–	0.04%	119
2024 Q3	$115K	Hold	20,300	–	–	0.02%	130
2024 Q2	$85.7K	Hold	20,300	–	–	0.02%	123
2024 Q1	$103K	Hold	20,300	–	–	0.02%	125
2023 Q4	$189K	Hold	20,300	–	–	0.04%	122
2023 Q3	$133K	Hold	20,300	–	–	0.03%	118
2023 Q2	$165K	Hold	20,300	–	–	0.04%	120
2023 Q1	$174K	Buy	+20,300	New	+$203K	0.04%	117

Other funds holding AVXL

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM